CTF Young Investigator Award
CTF’s longest running program, YIA provides two-year awards for young scientists early in their careers, bringing them into the NF field and helping to establish them as independent investigators. Implemented over 30 years ago by the Foundation, the YIA program was until 2006 CTF’s sole ongoing grant mechanism. Click here for Applicant Eligibility Guidelines.
Though a number of YIAs have made significant research findings and made notable publications the main function of the YIA program has been as a ‘seeding mechanism’ for researchers who went on to secure larger grants from NIH and CDMRP NFRP. CTF’s “seeding” of the NF field with new talent has been hailed as a key reason why NF research has grown rapidly in the past 25+ years. Between 2005 and 2008 the YIA program doubled in size from 5 to 10 funded awards (8 postdoctoral and 2 predoctoral). In the same period number of applications submitted increased from 16 (2005) to 34 (2008). The success rate of this program remains extraordinarily high at around 30%. CTF funded 11 YIAs in 2012 and 9 YIAs in 2013 with grants ranging from $64,000 to $108,000 each. The submission window for the Young Investigator Awards opens in January each year.
2015 YOUNG INVESTIGATOR AWARD RECIPIENTS
POST DOCTORAL RECIPIENTS
Dr. Dipak N. Patil, Scripps Research Institute, Florida
"Understanding the GPCR driven interaction of NF1 with G proteins"
Dr. Aubin Moutal, University of Arizona
"MOLECULAR TARGETING OF MIGRAINE IN THE NF1 POPULATION"
Dr. Lei Xing, The University of North Carolina at Chapel Hill
"MAPK/ERK hyperactivation on neural circuit development in NF-1"
Miss Vanessa Merker, Massachusetts General Hospital (The General Hospital Corp)
"Understanding Diagnostic Delay in Schwannomatosis: A Patient-Centered Approach"
Mrs. Marisa Ann Fuse, University of Central Florida Research Foundation, Inc.
"Novel Human Xenograft Mouse Model for Evaluation of PI3K Inhibitors in Neurofibromatosis Type 2-Associated Schwannomas"
Mr. Seyed Mohammad Ebrahim Tahaei, Vanderbilt University Medical Center
"The inhibitory role of EGFR signaling in NF1 Pseudoarthrosis"